Pasithea Therapeutics (KTTA) Assets (2020 - 2026)
Pasithea Therapeutics (KTTA) posted Assets of $56.4 million for Q1 2026, down 6.45% sequentially from $60.2 million in Q4 2025, and up 284.44% YoY from $14.7 million in Q1 2025.
Pasithea Therapeutics (KTTA) Assets (2020 - 2026) Analysis & Trends
Pasithea Therapeutics has reported Assets for 7 years, with the latest figure at $56.4 million in Q1 2026.
- Quarterly Assets rose 284.44% year-over-year to $56.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.4 million (up 284.44% YoY) and the FY2025 annual result came in at $60.2 million, up 274.98% from the prior year.
- Assets slipped to $56.4 million in Q1 2026 per KTTA's latest filing, from $60.2 million in the prior quarter.
- Over five years, Assets peaked at $60.2 million in Q4 2025 and troughed at $13.6 million in Q3 2025.
- A 5-year average of $33.7 million and a median of $30.7 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2026: Assets plunged 53.7% in 2024, then surged 284.44% in 2026.
- Over 5 years, Assets stood at $45.2 million in 2022, then plunged by 42.19% to $26.1 million in 2023, then plunged by 38.49% to $16.1 million in 2024, then soared by 274.98% to $60.2 million in 2025, then fell by 6.45% to $56.4 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $56.4 million, $60.2 million, and $13.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Pasithea Therapeutics | 16.97 Mn | 16.97 Mn | - | 51.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.35 Mn |
| Dec 31, 2025 | 60.24 Mn |
| Sep 30, 2025 | 13.63 Mn |
| Jun 30, 2025 | 17.01 Mn |
| Mar 31, 2025 | 14.66 Mn |
| Dec 31, 2024 | 16.06 Mn |
| Sep 30, 2024 | 18.64 Mn |
| Jun 30, 2024 | 17.66 Mn |
| Mar 31, 2024 | 22.41 Mn |
| Dec 31, 2023 | 26.12 Mn |
| Sep 30, 2023 | 30.66 Mn |
| Jun 30, 2023 | 38.15 Mn |
| Mar 31, 2023 | 42.04 Mn |
| Dec 31, 2022 | 45.18 Mn |
| Sep 30, 2022 | 49.61 Mn |
| Jun 30, 2022 | 53.03 Mn |
| Mar 31, 2022 | 51.08 Mn |
| Dec 31, 2021 | 53.32 Mn |
| Sep 30, 2021 | 21.04 Mn |
| Dec 31, 2020 | 247,958.00 |